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Legionnaires’ disease is primarily a pneumonic process caused by Legionella pneumophilia, a gram-negative aerobic bacillus
but also has multiple system involvement. The most common manifestation is encephalopathy suggesting a generalized brain
dysfunction but focal neurological manifestations have been reported. We report a patient with Legionella pneumonia associated
with cerebellar dysfunction and unilateral facial nerve weakness. 51-year-old previously healthy male presented with shortness of
breath,cough,slurredspeech,andunsteadinessonfeetassociatedwithmalaise,feversandmyalgias.Patient’sfamilyreportedfacial
asymmetry for 2 days. Patient had no signiﬁcant medical history and was not on any medication. He denied smoking, alcohol or
illicit drug use. Chest X-ray showed bilateral lower lobe inﬁltrates. Urinary antigen assay for Legionella pneumophilia serogroup
1 was positive. Patient was started on intravenous moxiﬂoxacin. On day 5 the patient was discharged home and continued oral
moxiﬂoxacin for two weeks. After the two weeks, his respiratory symptoms, gait ataxia and dysarthria resolved. We report the ﬁrst
case of Legionnaires’ disease with cerebellar dysfunction and seventh nerve palsy. Legionnaires’ disease should be considered in
patients with any neurological symptoms in the settingof pneumonia. Failure torecognize and treat the infection may lead to poor
outcomes.
1.Introduction
Legionnaires’ disease was described initially in 1976 among
delegates of American Legion Convention in Philadelphia
[1]. It is primarily a pneumonic process caused by Legionella
pneumophilia, a gram-negative aerobic bacillus but also has
multiple system involvement. Neurological manifestations
arewellrecognizedandmaydevelopin40%–50%ofpatients
[2]. The most common manifestation is encephalopathy
suggesting a generalized brain dysfunction but focal
neurological manifestations such as brainstem dysfunction,
cranial nerve dysfunction, and peripheral neuropathy have
also been reported as rare occurrence [3, 4]. Reports of
isolated cranial nerve involvement were of 3rd nerve, 6th
nerve, and 7th nerve dysfunction. This paper describes
a patient with Legionella pneumonia associated with
cerebellar dysfunction and unilateral facial nerve weakness.
2.CaseReport
A 51-year-old previously healthy male presented to our
department with complaints of shortness of breath, cough,
slurred speech, unsteadiness on feet associated with malaise,
fevers, and myalgias. The symptoms began seven days prior
to presentation with progressively worsening fevers with
chills, generalized myalgias, and malaise. Two days later,
he developed dyspnea and dry cough. He also complained
of nausea, vomiting with watery diarrhea, headache with
slurredspeech,andfeelingunsteadyonthefeet.Thepatient’s
family reported facial asymmetry for last 2 days.
Patient denied any hemoptysis, head trauma, loss of
consciousness, dizziness, or confusion. He worked as a
security guard in a local company. He denied recent travel
or any contact with sick patients. Patient did not have any
signiﬁcantpastmedicalhistoryandisnotonanymedication.
He denied smoking, alcohol use, or any illicit drug usage.
On physical examination, he appeared ill, diaphoretic,
and in respiratory distress. His vital signs were as follows:
respiratory rate was 24 per min, pulse rate 102 per min,
blood pressure 140/73mm of Hg, SpO2 of 95% on room
air, and oral temperature 39.3◦C. His chest examination
revealed inspiratory crackles in both the lower lung ﬁelds.
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with dysarthria, but tongue movement was normal and in
midline. He had no nystagmus or gaze paralysis. He had
upper motor neuron-type weakness of left facial nerve. Gait
was ataxic with positive Romberg’s test. He had normal
tone, strength, reﬂexes, and coordination in all the four
extremities. There was no neck rigidity.
Laboratory abnormalities are as shown in Table 1. Chest
X-ray (shown in Figure 1) showed bilateral lower lobe
inﬁltrates. EKG showed sinus tachycardia at rate of 102/min
but no other acute changes. Bacterial blood cultures were
negative. Urinary antigen assay for Legionella pneumophilia
serogroup 1 was positive. Sputum cultures were negative for
Legionella. Noncontrast CT of brain was normal. Magnetic
resonance imaging (MRI) scan of the brain with gadolinium
was normal. Electroencephalography (EEG) showed gener-
alized slowing of the background activity suggestive of mild
encephalopathy but no focal spikes.
The patient was started on intravenous moxiﬂoxacin
along with the routine supportive care. By day 4, diar-
rhea completely resolved. His respiratory symptoms and
dysarthria also started improving, but the ataxia and facial
weakness persisted. His chest X-ray (shown in Figure 2)a t
this time was clear of any inﬁltration that was noted on
admission.
On day 5, the patient was discharged home with plan of
continuing oral moxiﬂoxacin for two more weeks. Neurolog-
ical examination at this time revealed mild dysarthria, mild
ataxia needing a walking aid, and persisting facial weakness.
He was followed up in our outpatient clinic in 2 weeks.
At this point, his respiratory symptoms, gait ataxia, and
dysarthriacompletelyresolved.Hisfacialweaknessimproved
moderately, but there was still some facial asymmetry. A
chest X-ray repeated at this time was normal.
At 3 months, the patient still had persisting unilateral
facial weakness.
3. Discussion
Legionnaires’ disease was described in 1976 in delegates of
American Legion Convention [1]. It is now described as an
infection with multisystem involvement [5]. Neurological
complications occur in 40%–50% of cases [2]. Common
neurological manifestations include headache, somnolence,
andvaryingdegreesofencephalopathy.Lessfrequentpresen-
tations are brain stem dysfunction, cerebellar dysfunction,
peripheral neuropathies, pyramidal tract dysfunction, cra-
nial nerve palsies, memory loss, seizures, aﬀective disorders,
and hallucinations [3, 4].
The cranial nerve palsies that have been described so far
are occulomotor and abducens nerve involvement and facial
nerve [4, 6, 7].
Our patient presented with symptoms consistent with
pneumonia along with focal neurological signs. The diag-
nosis of legionella pneumonia was made by detection of
L. pneumophila serogroup 1 antigenuria by immune assay.
Brain CT, MRI, and EEG were normal. Thyroid function
tests were normal. Antinuclear antibody screen and C3 and
C4 complement levels were normal to exclude any vasculitic
process. As the neurological symptoms and pneumonia
Table 1: Abnormal laboratory data.
Sodium 130meq/L
potassium 3.3meq/L
BUN 25mg/dL
creatinine 1.1mg/dL
alanine aminotransferase 231U/L
aspartate aminotransferase 378U/L
myoglobin 665ng/mL
creatinine phosphokinase 721U/L
C-reactive protein 9.2mg/dL
Figure 1: Chest X-ray on day 1 showing bilateral basal inﬁltration.
occurred concurrently and the improvement in ataxia,
dysarthria, and facial weakness occurred with the treatment
of pneumonia, we presumedthat the neurological symptoms
were due to Legionella pneumonia.
A computer-based search of literature (MEDLINE; years
1948–December 2010) without language restriction was
performed. Key words used in the search were legionella,
legionella pneumophila, legionnaires’ disease, legionellosis,
cranial nerves, nerve, cerebellar, and neurology. The cita-
tions in all identiﬁed articles were evaluated and English
abstracts of foreign language articles were also evaluated.
The combination of Legionnaires’ disease and seventh nerve
involvement has never been reported in the past [4, 8].
We report the ﬁrst case of Legionnaires’ disease with
cerebellar dysfunction and seventh nerve palsy. The cere-
bellar involvement was mild aﬀecting the trunk presenting
as gait ataxia and dysarthria. There was no nystagmus or
lateralizing signs. The seventh nerve palsy was unilateral and
upper motor neuron type.
Cerebellar dysfunction is rare but well documented in
Legionnaires’ disease. Shelburne et al. reported 29 cases of
cerebellardysfunctioninLegionnaires’disease[9],andJohn-
son et al. reported the incidence of cerebellar dysfunction
is 3.7% in Legionnaires’ disease [2]. As per Shelburne et al.
themostfrequentlyreportedcerebellarsymptomsinLegion-
naires’ disease are dysarthria (79%) and ataxia (72%) [9].Case Reports in Medicine 3
Figure 2: Chest X-ray on day 4 showing resolution of the earlier
changes.
I nl i t e r a t u r e ,w ec a m ea c r o s so n l yt w oc a s e sw i t hf a c i a l
nerve palsy in the setting of legionellosis, and they were
diﬀerent from our case for multiple reasons.
The case of bilateral facial nerve palsy reported by
Morgan and Gawler was in the setting of severe and
progressive peripheral neuropathy and encephalopathy [8]
which was not present in our patient. The type of facial
weakness has not been clearly described. The facial nerve
palsy in our patient was upper motor neuron type as per our
clinical examination.
The second case was reported by Johnson et al., in the
setting pneumonia and confusion on admission, rapidly
progressed to coma and later developed left facial nerve
palsy and hemiparesis. Nuclide brain scan with technetium
−99-m pertechnate which was normal on admission, later,
it demonstrated multiple focal defects in both the hemi-
spheres. The patient eventually succumbed to severe sepsis,
and at autopsy, necrotizing hemorrhagic leucoencephalitis
with bacilli morphologically similar to legionella has been
identiﬁed. In this case, secondary causes for the neurological
presentations such as a vascular event could have been
possible [2].
The pathogenesis of neurological dysfunction in Legion-
naires’ disease is unclear. Various theories have been pro-
posed suggesting direct invasion, toxin, or immune-media-
ted or reversible ischemia. Legionella has been identiﬁed
in brain on rare instances in autopsy reports suggesting
direct invasion of central nervous system [4, 10, 11]. In the
absence of direct invasion, neurotoxin, or immune-mediated
mechanisms have been proposed as possible mechanisms of
neurological involvement. However, clear evidence support-
ing either of the mechanisms is lacking [12].
Focal areas of ischemia has been suggested by Imai et al.
by demonstrating multiple areas of hypoperfusion in cere-
bellum and frontal lobe using single photon emission
computed tomography (SPECT) with Tc-99m hexamethyl-
propyleneamine oxime (HMPAO) reconstructed using the
three-dimensional stereotactic surface projection (3D-SSP)
technique 3D [13]. Their patient had a reversible lesion in
the splenium of corpus callosum, identiﬁed on magnetic
resonance imaging (MRI) scan of the brain.
The utility of functional imaging of brain such as
single photon emission computed tomography (SPECT)
and positron emission tomography (PET) in diagnosis of
Legionnaires’ disease with neurological dysfunction was
predicted by Morgan et al. [14].
The treatment of this condition is antibiotics and
supportive care. High-dose corticosteroids have been used
in life-threatening conditions, and the evidence for it is only
anecdotal [12].
The prognosis of neurological deﬁcits is not well stud-
ied due to the limited number of cases. In general, the
encephalopathy and coma are largely reversible with mild
residual deﬁcits. The focal deﬁcits such as cerebellar and gait
disturbance tend to persist for long periods [4, 12].
In retrospect, we identiﬁed the following investigations
which would have been interesting in our patient. Although
the patient management and outcome would not have
changed, functional brain imaging could have helped us to
localize the lesion. Though the utility of cerebrospinal ﬂuid
analysis (CSF) is undetermined, it may be helpful to rule out
other infective causes.
In conclusion, Legionnaires’ disease should be strongly
considered in patients with any neurological symptoms in
the setting of pneumonia. In such a setting, full evaluation
has to be performed to exclude other etiologies. Failure to
recognizeandtreattheinfectionmayleadtopooroutcomes.
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